Market ekes out small gains; breadth positive
Under that agreement, Glenmark is entitled to 180 days of exclusivity with respect to its Hydrocortisone Butyrate Cream, as it is the first generic company to file an abbreviated new drug application (ANDA) for the product. Earlier this week …
Read more on Business Standard

Pre-Open Stock Movers 10/10: (ACUR) (CHTP) (NFLX) Higher; (CTXS) (RT …
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) 9% HIGHER; said the FDA notified the Company that the New Drug Application (NDA) seeking approval to market NORTHERA™ (droxidopa), an orally active synthetic precursor of norepinephrine, for the …
Read more on StreetInsider.com (subscription)